Interactive amino acid sequence guide

The amino acid sequence infographic of antibody products is provided through an interactive user interface, which solves the problem of difficult to find and compare antibody product information in the existing system, and achieves rapid and effective screening and identification of antibody products.

CN119072751APending Publication Date: 2024-12-03PIERCE BIOTECHNOLOGY INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380035052.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-08
Filing Date
2023-03-07
Publication Date
2024-12-03

Smart Images

  • Figure HDA0005091609540000011
    Figure HDA0005091609540000011
  • Figure HDA0005091609540000021
    Figure HDA0005091609540000021
  • Figure HDA0005091609540000031
    Figure HDA0005091609540000031
Patent Text Reader

Abstract

Disclosed herein are methods and systems for generating a computer-implemented interactive graphical user interface for utilizing visual evaluation of sequence information to facilitate discovery of appropriate antibody products. A list of antibody products is generated within the graphical user interface. The list of antibody products is responsive to user interaction. The antibody product list comprises at least one antibody product, and the antibody product comprises corresponding sequence information and product specification. A sequence information map is generated based on the corresponding sequence information, wherein the sequence information map includes an amino acid sequence region indicator of interest. And displaying the sequence information graph compared with a plurality of sequence information graphs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure generally relates to online or other electronic systems for accessing antibody product information and identifying and obtaining relevant antibody products. Background Art

[0002] Antibody products are categorized and provided to aid researchers in many fields, including, for example, cell analysis, genomics, proteomics, drug discovery, biodefense, environmental diagnostics, epigenetics, and stem cell research. Existing online or other electronic catalogs readily provide product availability and pricing information. However, other important product information is not provided in a form that is easy enough to digest and compare a large number of antibody products. Summary of the invention

[0003] As consumers of antibody products, scientists and researchers often need to analyze information about the characteristics of a particular product, beyond just availability and price. Scientists may also be interested in determining the availability of all products relevant to their area of ​​research (e.g., all products that can be used to study a specific amino acid area of ​​interest within a target protein).

[0004] However, using currently available systems, it is time-consuming and cumbersome to find the right antibody product to use in a particular experiment. Information about the antigen or immunogen used to produce the antibody product is critical for identifying the best antibody product for a particular purpose. However, current systems do not have sufficient tools to provide this information. Such information is often hidden in the product description, and scientists and researchers must manually parse through multiple product descriptions one by one to determine the antigen or immunogen information. The time-consuming aspect of these searches is complicated because text-based information must be reviewed from a detailed description of each antibody product, and the information cannot be easily compared between products.

[0005] Therefore, there is a need for an intelligent, customized, and user-friendly visual representation of the large amount of amino acid sequence data associated with antibody products that is easily accessible, interpreted, and compared by scientists and researchers.

[0006] Embodiments of the present invention relate to interactive user interfaces for antibody products. The interface enables visual assessment of immunogen or antigen information. Some embodiments provide a specific, structured graphical user interface that is paired with a specified function directly related to the structure of the graphical user interface for determining the correct antibody product. Some embodiments provide specific structures, such as information graphs, that allow users to avoid the arduous task of navigating through each product and reviewing each product description in a separate window to identify and compare sequence information.

[0007] Certain embodiments may provide one or more of the following technical advantages. Advantages and efficiencies are gained from presenting details in a compact visual format. The disclosed embodiments provide significant improvements in reviewing, analyzing, evaluating, and comparing immunogen or antigen information corresponding to antibody products by using user-friendly infographics that convey the amino acid sequence information of each product, which is otherwise difficult to digest, analyze, or visualize, and is particularly difficult to compare between antibody products. The infographics are provided in an organized and compact format that conveys previously hidden and confusing information at a glance. The visually interactive elements of the user interface embodiments also facilitate efficient searching and identification of related antibody products. In this way, the complexity of the immunogen or antigen information is converted into a simple, easy-to-understand visual format, providing a highly intuitive interface in which high-level features (e.g., amino acid sequence information) are easily discernible.

[0008] Various computer-implemented systems, methods, and articles of manufacture for an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information are described herein, which computer-implemented systems, methods, and articles of manufacture can improve determination of the correct antibody product for a particular experiment with respect to the various challenges described above.

[0009] Various objects, features, aspects and advantages of the present subject matter will become more apparent from the following description and accompanying drawings, in which like reference numerals represent like components. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 is a flow chart illustrating a method for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0011] Figure 2 is a flow chart illustrating a method for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0012] Figure 3 is a block diagram illustrating interactive interface components for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0013] Figure 4is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0014] Figure 5 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0015] Figure 6 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0016] 7A to 7C is a block diagram illustrating an interactive amino acid sequence slider for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0017] FIG. 8A to FIG. 8D is a block diagram illustrating an antibody product information map for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0018] Fig. 9 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0019] Fig.10 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0020] Fig.11 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0021] Fig.12 is a block diagram illustrating a three-dimensional (3D) interactive filter for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0022] Fig.13 is a block diagram illustrating a 3D infographic for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information, according to various embodiments.

[0023] Fig.14 An exemplary computer system is shown that can be configured by a computer program product for an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating the discovery of appropriate antibody products to practice embodiments of the present invention using visual assessment of immunogen or antigen information.

[0024] Although the present invention is described with reference to the above drawings, the drawings are intended to be illustrative and other embodiments are consistent with the spirit of the invention and are within the scope of the invention. DETAILED DESCRIPTION

[0025] To provide a more thorough understanding of the present invention, the following description sets forth many specific details, such as specific configurations, parameters, examples, etc. However, it should be recognized that such description is not intended as a limitation on the scope of the present invention, but is intended to provide a better description of exemplary embodiments.

[0026] According to various embodiments, the present disclosure may relate to devices, instruments, systems and methods for an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating the discovery of appropriate antibody products using visual assessment of immunogen or antigen information.

[0027] It should be appreciated that the disclosed technology provides a number of advantageous technical effects, including an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating the discovery of appropriate antibody products using visual assessment of immunogen or antigen information.

[0028] It should be understood that the disclosed technology provides many advantageous technical effects, including interactive computer interface methods for visually reviewing, identifying and comparing antibody products. The disclosed technology has been designed to support review, identification and comparison accuracy at a scale and speed that cannot be achieved using manual efforts.

[0029] It should also be appreciated that the following description is not intended as an extensive overview and that, therefore, the concepts may be simplified for the sake of clarity and conciseness.

[0030] Research is critical for researchers to discover the correct antibody to use in a given experiment. Many factors determine which antibody to choose. Some factors are easily summarized in a table and are applicable to standard filtering and sorting. Information related to antigens or immunogens is not available in this format. The antigen / immunogen originally used to generate the antibody can be a critical factor in choosing the right antibody. This information is often buried in the details listed on a single product page and is not easily compiled, reviewed, and compared.

[0031] The present disclosure provides a graphical interface that enables users to quickly view, filter, sort or compare antibody lists according to antigen / immunogen. The present disclosure provides user-friendly access to immunogen information in a graphical interface that allows rapid filtering, sorting and comparison between antibody products.

[0032] The present disclosure provides an antigen / immunogen search utility in a web-based antibody search interface, which converts the text / digital information of the sequence of a given target protein and the antigen / immunogen used to generate antibodies against the target protein into a graphical format presented in a visual interface.

[0033] The present disclosure enables users to quickly view and compare options for all available antibody options on a single page and in a filterable format that also includes the ability to filter results by position within the full-length target protein.

[0034] Interface elements are visually distinguished by shape, color, size, length, position, location, grouping or behavior, or by alignment or juxtaposition of associated elements or representation indicators, so as to help users identify specific antibody products based on amino acid regions of interest or fragments of interest within the full-length amino acid sequence of the target protein. This distinction can be made by the content provider or by the user.

[0035] Interface elements are used to provide visual information related to the amino acid sequence associated with the target protein. The amino acid sequence has a starting amino acid and a terminating amino acid. Proteins are made up of a linear chain of amino acids connected to each other by bonds. At the beginning of the protein is the N-terminus, and at the end of the protein is the C-terminus. The N-terminus is the free end of the chain that ends in a carboxyl group, and the C-terminus is the free end of a carboxylic acid, with the two acid groups connected together through the length of the protein chain. The amino acid sequence is written or displayed from left to right, N-terminus to C-terminus.

[0036] Although the term "generating" is used to describe presenting an infographic or interface element, the infographic may be pre-generated, stored, retrieved, and displayed as needed. Additionally, the interface element or infographic may be an image, video, digital layer, virtual representation, tactile, or a combination thereof.

[0037] The graphical user interface includes an antibody product representation. The user searches for one or more antibody products based on an amino acid region or fragment of interest associated with each product. Each antibody has been prepared against a protein or a sequence corresponding to a portion of a protein. The immunogen has been injected into an animal to generate an antibody response. The resulting antibodies bind to specific antigens or peptide sequences contained in the target protein.

[0038] In the present disclosure, antigen or immunogen may refer to an amino acid sequence associated with producing a specific antibody product. In the present disclosure, protein and target may be used interchangeably and may also refer to the full-length protein that is the target for preparing an antibody product.

[0039] The graphical user interface facilitates identification of the antigen or immunogen corresponding to the antibody product and provides a quick and easy way to visually sort through information related to the antigen or immunogen. The amino acid sequence information graph provides an easy way to determine which part of the protein the corresponding antibody product is likely to recognize and react to.

[0040] When epitope information is available for a specific antibody product, the infographic may include a visual indication of the epitope information. Epitopes are typically smaller and more specific than the amino acid sequence that represents an antigen or immunogen. An epitope is a specific binding site for an antibody. That is, within a target protein, an epitope is a small area that an antibody recognizes and binds to. For example, a complete protein can be used as an immunogen, but an antibody, particularly in the case of a monoclonal antibody, may only recognize a specific portion of a protein target, called an epitope. In the case of a polyclonal antibody, there will be no specific epitope, and the antibody may bind to multiple regions of a protein. In some embodiments, the epitope is unknown, and only the approximate antigen sequence is known.

[0041] Figure 1is a flow chart 100 illustrating a method for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information.

[0042] In one embodiment, a method 100 for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information begins at step 101 .

[0043] The method detects user interactions in a graphical user interface at step 101. The user interactions include user events on the interactive graphical interface.

[0044] In step 102, the method generates an antibody product list including at least one antibody product. The antibody product list includes the antibody product and a corresponding description or infographic.

[0045] The method identifies the immunogenic information and product specifications of each antibody product at step 103. The immunogenic information includes amino acid sequence information.

[0046] At step 104, the method generates an immunogen information graph based on the immunogen information, including a visual representation of an amino acid sequence range or fragment of the immunogen displayed relative to a target protein sequence range or fragment, and displays a visual indicator of a region of interest. The region of interest includes an amino acid sequence range or fragment that includes amino acids from which the antibody product is derived.

[0047] At step 105, the method displays an immunogen profile graph aligned with respect to a plurality of immunogen profile graphs in the antibody product list. This visual alignment provides a visual reference point for the amino acid region of interest relative to the reference protein sequence and relative to other antibody product immunogens / antigens. In some embodiments, the visual alignment includes alignments in multiple orientations or dimensions, including, for example, vertical alignment, horizontal alignment, forward alignment, and backward alignment, etc.

[0048] At step 106, the method detects user interaction with the immunogen slider. User interaction includes any user-initiated event associated with navigating the interactive interface. The interaction includes moving the slider, or interacting with a constraint indicator corresponding to a boundary value or constraint value along a reference target protein configured as a filter element in the interface. The amino acid value indicated by the slider indicator will be used to determine which products to filter in the product list.

[0049] The method updates the product list based on the new slider value at step 107. For example, if the new slider value indicates that the region or fragment of interest is between amino acid 20 and amino acid 100, the product list will be updated to include products where the immunogen / antigen amino acid sequence values ​​are between 20 and 100, and exclude products where the amino acid values ​​are below 20 and above 100.

[0050] Figure 2 Flowchart 200 is a method for generating a computer-implemented interactive graphical user interface, which is used to facilitate the discovery of suitable antibody products using visual assessment of immunogen or antigen information. In one embodiment, method 200 begins at step 201, during which the computer-implemented interactive graphical user interface receives a request to display an antibody product based on an immunogen and an amino acid sequence region of interest. In some embodiments, the request can be initiated by user interaction. In some embodiments, the request can be triggered by an automated computerized process.

[0051] At step 202, the method identifies available values ​​for the region of interest, such as, but not limited to, starting amino acid, ending amino acid, amino acid range of interest, estimated amino acid region or fragment of interest, epitope, and phosphorylation site.

[0052] At step 203, the method queries each product in the product list to determine if there are any products with antigen / immunogen amino acid values ​​within the requested range.

[0053] At step 204, if the product is outside the requested range, the method will not display the antibody product. In other words, the antibody product will be filtered out.

[0054] At step 205, if the product is within the requested range, the method will display the antibody product. In other words, the antibody product will not be filtered out and will be included in the product list.

[0055] In step 206, the method will generate an information graph based on the available values ​​of each product included in the product list. In some embodiments, the information graph can be pre-generated, stored and retrieved as needed. The information graph will include all available values ​​related to the region of interest, such as but not limited to the starting amino acid, the ending amino acid, the amino acid range of interest, the estimated amino acid region of interest, the epitope and the phosphorylation site. In some embodiments, a toggle key (toggle) or another interface element can be used to control which values ​​in the region of interest should be generated as part of the information graph. In some embodiments, a toggle key or another interface element can be used to identify whether to display a product including a specific value related to a specific region of interest. For example, there can be a toggle key that only displays a product with epitope information. As another example, based on the availability of the amino acid value of the epitope, there can be a toggle key that displays or does not display the epitope information.

[0056] At step 206a, the method visually indicates the C-terminus, N-terminus, epitope, phosphorylation site, etc. For example, a region of interest is visually indicated to provide information about a specific available value associated with the immunogen / antigen. Other examples of visually indicated elements include starting amino acids, ending amino acids, amino acid ranges of interest, estimated amino acid regions of interest, epitopes, and phosphorylation sites, etc., when available.

[0057] At step 206b, the method positions the visual indicators relative to the values ​​on the full-length protein. For example, all information graphs can be presented one below the other and below the full-length target protein and visually positioned based on their corresponding amino acid values. Thus, if Fig. 9 , Fig.10 and Fig.11 As shown, for example, the starting amino acid and the ending amino acid displayed in each infographic are visually positioned relative to those amino acids displayed in the other infographics and relative to visual indicators for the full-length target protein sequence and / or a user-selected sequence range within the full-length target protein sequence.

[0058] Figure 3 300 is a block diagram illustrating interactive interface components for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information according to various embodiments. In one embodiment, the interactive interface component 300 includes an interactive sequence slider 310, an antibody product list 320, and an amino acid sequence information graph 330. The interactive sequence slider 310 includes an N-terminus 311, a C-terminus 312, a starting amino acid 313, an ending amino acid 314, and a toggle key 315.

[0059] In some embodiments, the toggle key 315 controls whether additional information on the information graph is displayed. As an example, the additional information includes epitope information, and the toggle key 315 controls whether the additional information is displayed via the indicator 335. In some embodiments, the additional information can be overlaid on top of the amino acid sequence information graph 330, or partially overlap the amino acid sequence information graph. In some embodiments, overlapping includes blending, superimposing, layering, or merging multiple images or information indicators.

[0060] User interaction with the interactive sequence slider 310 results in updating the list 316 , for example, including updating the antibody product list 320 and / or updating the protein sequence information and product specifications 321 included in the antibody product list 320 .

[0061] The amino acid sequence information map 330 includes a starting amino acid 333, an ending amino acid 334, an indicator 335, a region of interest 331, and a full amino acid sequence range 332. In some embodiments, the indicator 335 includes epitope information.

[0062] In some embodiments, a visual representation of amino acid sequence information associated with or included as part of the information graph 330 can overlap, blend, overlay, or merge with the visual representation of the information graph. The amino acid sequence information includes a starting amino acid 333, an ending amino acid 334, an indicator 335, and a full amino acid sequence range 332, a region of interest 331, a boundary or constraint element, an amino acid range of interest, an estimated amino acid region of interest, an epitope, a phosphorylation site, and the like.

[0063] In some embodiments, data overlays can be used to include more information in a visual format. Additional information related to the region of interest can be overlaid on an interface element (including an image, video, or another type of interface element) representing the target protein. For example, a data overlay can include epitope information for an antibody product, or multiple product information.

[0064] Overlapping antigen or immunogen data can include, for example, border or constraint elements, such as starting and / or ending amino acids, epitopes, binding regions or fragments of interest, or border or constraint intervals, as overlapping layers on a base layer (such as a full-length protein). By using overlap, a user can quickly see which region of the protein the antibody is directed against. The overlapping coordinates correspond to and are aligned on the amino acids of the full-length protein.

[0065] In some embodiments, the interactive interface component includes a generated multidimensional protein model that includes a visual representation of at least one level of protein structure. In some embodiments, the protein structure includes one of a primary protein structure, a secondary protein structure, a tertiary protein structure, and a quaternary protein structure. The interactive interface can position an amino acid sequence region indicator of interest on at least one level of protein structure.

[0066] Figure 4 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information according to various embodiments. In one embodiment, product page 400 is configured to display product information for a beta catenin target family.

[0067] Navigation options 410 include options for product pages, image pages, and antigen pages. Products are underlined in navigation options 410, indicating that the user is currently on the product page. In some embodiments, user events (e.g., hovering a pointer over a specific option or element in navigation options 410) can cause attention to or highlight options by underlining the options (including, for example, highlighting the options using a color or another visually distinguished characteristic). In some embodiments, when clicking or selecting the antigen option, the user is taken to the antigen product list page.

[0068] Figure 5 5 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information according to various embodiments. In this example, interactive interface 500 is a product page for a polyclonal antibody to beta catenin, including an antigen description 511. From this page, a user can use an antigen link 510 to navigate to an expanded information view of an antibody product for a full-length protein, including, for example, an amino acid information graph view including an amino acid sequence range of the antigen or immunogen.

[0069] Figure 6 600 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information according to various embodiments. In one embodiment, the interactive interface 600 is a product page for a β-catenin polyclonal antibody, including a description 611 and an amino acid information graph 612.

[0070] In some embodiments, amino acid information graph 612 is displayed in response to a user interaction event, including, for example, clicking on link 510, which results in dynamically expanding the viewing area to include additional information associated with the antigen or immunogen corresponding to the antibody product.

[0071] The amino acid information graph 612 includes the immunogen or antigen information and provides a visual representation of the immunogen range (e.g., amino acid range 750 to 781) for the full-length protein. From this page, the user can navigate to the list link 610 by clicking "View all antibodies by antigen range". After clicking the list link 610, the user is taken to a page that includes a list of antibody products for β-catenin.

[0072] In some embodiments, the user can view the immunogen or antigen range for the full-length protein in the amino acid information graph 612. In this embodiment, the full-length protein range of the target protein is from amino acid 1 to amino acid 781, and the immunogen or antigen is between amino acid 750 and amino acid 781. Information about how the antibody was derived is also described in the description 611. In some embodiments, the free text description information is used to parse the antigen or immunogen amino acid related information, such as the starting amino acid and ending amino acid information.

[0073] 7A to 7C is a block diagram showing an interactive amino acid sequence slider for generating a computer-implemented interactive graphical user interface according to various embodiments, which is used to facilitate the discovery of appropriate antibody products using visual assessment of immunogen or antigen information. Examples show filter elements for inputting the starting amino acid and the ending amino acid of the immunogen or antigen of the target protein. In these examples, the target protein is human beta catenin and is 781 amino acids long. The slider element is used to narrow the protein range from 781 to the desired length within the desired position or positioning relative to the target protein. The slider element can be moved along the entire target protein range to identify the amino acid filter value of the antibody product list. When the slider moves, the shaded area representing the amino acid region of interest expands or contracts accordingly, indicating the selected amino acid region of interest within and between the sliders.

[0074] In some embodiments, any number of slider elements can be used to identify any number of intervals or ranges of amino acids of interest. In some embodiments, additional interface elements can be used to indicate filtering criteria or parameters about amino acids of interest, and the filtering criteria or parameters are used to include or exclude antibody products from the antibody product list, including, for example, annotation interface elements, epitope indication interface elements, phosphorylation site indication interface elements, or atomic structures or atomic coordinate interface elements for indicating filtering criteria or parameters. In some embodiments, additional interface elements can indicate the level of protein structure, including one of primary protein structure, secondary protein structure, tertiary protein structure, and quaternary protein structure. In some embodiments, interface elements such as dynamic selection tables can be used in interactive graphical user interfaces implemented by computers. For example, in a drop-down menu or button group, a dynamic selection table can include one or more of a specific amino acid or amino acid sequence range of a given target protein, and can be responsive to user input to select at least one of a plurality of amino acid sequence ranges in a drop-down menu or radio button group. In addition, in some embodiments, interface elements such as digital input interfaces can be used in a graphical user interface implemented by a computer. The numerical input interface is responsive to user input to manually enter (eg, by typing into a text input box) the numerical position of a particular amino acid or a numerical range corresponding to a range of amino acid sequences for a given target protein.

[0075] Fig. 7A is a block diagram showing an interactive amino acid sequence slider interface component 700a, which includes an interactive sequence slider 710a, an N-terminus 720a, a C-terminus 730a, a left slider 721a, a right slider 731a, and a selected region of interest 750a. The interactive component 700a is configured to operate or function as a filter for antibody products by filtering out antigens or immunogens based on the amino acid region of interest controlled or constrained by the constraint indicators represented by sliders 721a and 731c.

[0076] In this example, slider 721a and slider 731a are located at amino acid position 1 and amino acid position 781, respectively. Slider 721a visually overlaps with N-terminus 720a, and slider 731a visually overlaps with C-terminus 730a, because the corresponding interface elements are located at the start position of amino acid 1 and the end position of amino acid 781. Therefore, only antibody products developed for amino acids located between amino acid 1 and amino acid 781 in the target protein (i.e., within the selected region of interest 750a) will be filtered for inclusion in the product list, while any antibody products with immunogens or antigens derived from amino acids outside of this range will be filtered out. Although not shown, the deselected region may represent a range or interval of amino acids of interest that are filtered out.

[0077] Figure 7B 700b, which includes an interactive sequence slider 710b, an N-terminal 720b, a C-terminal 730b, a left slider 721b, a right slider 731b, a selected region of interest 750b, and a deselected region 760b. Interactive component 700b is configured to operate or function as a filter for antibody products by filtering out antigens or immunogens based on the amino acid region of interest controlled by sliders 721b and 731c. In this example, sliders 721b and 731b are located at amino acid position 1 and amino acid position 500, respectively. Slider 721b visually overlaps with N-terminal 720b because both interface elements are at the start of amino acid 1. Therefore, only antibody products developed for amino acids located between amino acid 1 and amino acid 500 in the target protein (i.e., in the selected region of interest 750b) will be filtered to be included in the product list, while any antibody products with immunogens or antigens derived from amino acids outside this range will be filtered out. The unselected region 760b represents a range or interval of amino acids that are filtered out of interest.

[0078] Figure 7C 700c, which includes an interactive sequence slider 710c, an N-terminal 720c, a C-terminal 730c, a left slider 721c, a right slider 731c, a selected region of interest 750c, a deselected region 740c, and a deselected region 760c. The interactive component 700c is configured to operate or function as a filter for antibody products by filtering out antigens or immunogens based on the amino acid region of interest controlled by sliders 721c and 731c. In this example, sliders 721c and 731c are located at amino acid position 220 and amino acid position 500, respectively. Therefore, only antibody products developed for amino acids in the target protein located between amino acid 220 and amino acid 500 (i.e., in the selected region of interest 750c) will be filtered to be included in the product list, while any antibody products with immunogens or antigens derived from amino acids outside this range will be filtered out. The deselected region 740c and the deselected region 760c represent the filtered out ranges or intervals of amino acids of interest.

[0079] FIG. 8A to FIG. 8D is a block diagram illustrating an antibody product information graph in a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information according to various embodiments.

[0080] Fig. 8A is a block diagram showing an amino acid sequence information graph 800a, which includes a starting amino acid 810a, an ending amino acid 820a, and a region of interest 815a.

[0081] Figure 8B is a block diagram showing an amino acid sequence information graph 800b, which includes an amino acid region 815b, an amino acid region 805b, and an amino acid region 825b.

[0082] Figure 8C is a block diagram showing an amino acid sequence information graph 800c, which includes a starting amino acid 810c, an ending amino acid 820a, an amino acid region of interest 815c, an amino acid region 805c, and an amino acid region 825c.

[0083] Fig.8D is a block diagram showing an amino acid sequence information graph 800d, which includes a starting amino acid 815d and an amino acid region 825d.

[0084] FIG. 8B to FIG. 8D In some embodiments, the additional estimated, undefined or fuzzy region outside the boundary or constraint element is included. In some embodiments, these additional regions are indicated visually by fading out and away from the boundary element. The adjacent region on the additional undefined region indication amino acid sequence does not have the starting point or terminal point defined on the sequence. In this case, the actual starting point and terminal point on the amino acid sequence are unknown, unavailable or proprietary, and do not show which actual amino acids are included. In some embodiments, the shaded area represents the included amino acid's estimated error tolerance range. In some embodiments, the shaded area represents the amino acid length in the range of zero to twenty amino acids.

[0085] For example, the infographic 800d includes a starting amino acid 815d indicating that the sequence starts at amino acid 1. The additional region 825d fades out from the border element that is the starting amino acid 815d. In some embodiments, the product description corresponding to the infographic 800d is accompanied by a text description of the antigen or immunogen, which indicates that the antibody is derived from the N-terminus or N-terminal portion of the protein, in this case amino acid 1. That is, for example, as proprietary information of a third-party manufacturer or another entity, the starting point of the antibody product is known, but the end point is unknown or omitted. In addition, since the antibody associated with the infographic 800d is prepared for the immunogen at the N-terminus, and which exact amino acids are included is unknown or not provided by the third-party manufacturer, the end point is not defined, and this is depicted by fading out in the infographic 800d.

[0086] Fig. 9900 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products utilizing visual assessment of immunogen or antigen information according to various embodiments. In one embodiment, the interactive interface 900 is a product results page for a beta catenin polyclonal antibody product.

[0087] Interactive interface 900 includes search element 901, antigen link 902, navigation list 903, filter list 904, antibody product information 905, amino acid sequence filter 906, amino acid information graph 907, amino acid information graph 908, antigen class filter 909, link 910, and immunogen information 911. Antigen link 902 is underlined, indicating that the antigen page is being displayed.

[0088] In this example, link 910 includes the product web name that takes you to the product page. In this example, no top row filters from filter list 904 are selected, and antigen class filter 909 defaults to "human." In some embodiments, filters may include sliders, drop-down menus, or tabs.

[0089] Amino acid profile graph 907 shows the immunogen at the N-terminus of β-catenin. Amino acid profile graph 908 shows the immunogen at amino acid 25 to amino acid 75 of β-catenin. Filter 906 is shown to provide filtering capabilities and a visual reference for comparing results to the full length protein sequence.

[0090] In some embodiments, the order of sorting of the product list is based on at least one of the sequence range information, product name, and price. In some embodiments, the sorting based on the sequence range information sorts the products based on the value of the leftmost boundary element, and the reverse sorting sorts based on the value of the rightmost boundary element. For example, in the amino acid information graph 907, the leftmost boundary value is 1, and the following two products. In some embodiments, the amino acid information graph can be expanded or enlarged to provide more granular information about the amino acid of interest.

[0091] In some embodiments, the product list is sorted in order based on the N-terminus or the C-terminus. The default sorting can be based on the lowest leftmost value from left to right. If the user does not filter or interact with the slider, the infographic is visually aligned and sorted as moving from the left side of the protein to the right side.

[0092] Fig.101000 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information according to various embodiments. In one embodiment, the interactive interface 1000 is a product results page for a beta catenin polyclonal antibody product. The interactive interface 1000 includes a selection 1004, an amino acid sequence filter 1006, and amino acid information graphs 1007 to 1009.

[0093] Amino acid profile 1007 indicates that the antibody product is derived from or near the N-terminus of beta catenin. Amino acid profile 1008 indicates that the antibody product is derived from between amino acid 25 and amino acid 75. Amino acid profile 1009 indicates that the antibody product is derived from between amino acid 29 and amino acid 178.

[0094] Fig.11 11 is a block diagram illustrating an interactive user interface for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information according to various embodiments. In one embodiment, the interactive interface 1100 is a product results page for a beta catenin polyclonal antibody product. The interactive interface 1100 includes an amino acid sequence filter 1106, an amino acid information graph 1107 to an amino acid information graph 1110.

[0095] Amino acid profile graph 1107 indicates that the antibody product is derived from amino acids between 331 and 335. Amino acid profile graph 1108 indicates that the antibody product is derived from around amino acid 333. Amino acid profile graph 1109 indicates that the antibody product is derived from between amino acid 487 and amino acid 491. Amino acid profile graph 1110 indicates that the antibody product is derived from around amino acid 489.

[0096] Fig.12 1 is a block diagram illustrating a 3D interactive filter according to various embodiments for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information. In one embodiment, the 3D interactive amino acid sequence slider interface component 1200 is visually displayed as a ribbon diagram, also known as a Richardson diagram, which is a 3D schematic representation of protein structure. In this 3D display format, additional structural elements of the amino acid sequence can be visually indicated.

[0097] In this example, 3D interactive amino acid sequence slider interface component 1200 is shown as a strip, which displays the overall path and organization of the protein in 3D, and provides a visual indication of the details of the complete atomic structure of the protein. The secondary structure of the full range of amino acid sequences is shown in the strip, wherein the spiral and β sheet of the protein are displayed by corkscrew and arrows, respectively. In some embodiments, the α helix is ​​displayed as a curled strip or thick tube, and the β strand is displayed as an arrow, and the non-repeating coil or ring is displayed as a line or thin tube. The direction of the amino acid chain is indicated by an arrow. In some embodiments, the direction can be indicated by a color ramp, a color gradient, a pattern density, or other visual indications along the length of the strip as a whole. In addition, the 3D interactive amino acid sequence slider interface component 1200 provides a visual indication of whether the amino acid region of interest includes a coil, a turn, a chain, a spiral, and other visual indications of the molecular structure (including torsion, folding and unfolding).

[0098] In this example, the 3D interactive amino acid sequence slider interface component 1200 includes an N-terminus 1220, a C-terminus 1230, a left slider 1221, a right slider 1231, and a selected region of interest 1202. In this example, the filter slider corresponds to Figure 7C The filter slider shown in . Figure 7C The straight line is shown as the full range sequence of amino acids, and Fig.12 Shown is a 3D schematic representation of the full range sequence of amino acids.

[0099] Slider element 1221 and slider element 1220 can be moved around along the protein strip to identify the filter value of the product list. When the slider is moved, the shaded area expands or contracts accordingly, within and between the sliders, indicating the selected amino acid region of interest.

[0100] In some embodiments, as the slider values ​​are moved, the amino acid values ​​are dynamically updated. In this example, the amino acid value of slider 1221 is 25, and the amino acid value of slider 1231 is 45. As slider 1221 is moved along the strip generally toward the N-terminus 1220, for example, following the directional indication of the protein described above, the value decreases until it reaches 1 at 1220. In some embodiments, the directional indication can be determined by moving the slider and observing the decrease or increase in the amino acid value. As slider 1231 is moved along the strip generally toward the C-terminus 1230, the amino acid value increases from 45. In some embodiments, the 3D interactive filter is presented in full 3D using virtual reality or augmented reality technology.

[0101] In some embodiments, the 3D interactive amino acid sequence slider interface component 1200 can rotate in response to user events, including, for example, clicking and / or dragging a structure to rotate the interface component 1200. In some embodiments, the interface component 1200 is presented in full 3D using virtual reality or augmented reality technology. In some embodiments, the user can, for example, tap, pinch, and / or click the structure to zoom in more closely on the 3D interactive amino acid sequence slider interface component 1200 and / or make the interface component 1200 larger. In some embodiments, the user can shrink the interface component 1200 by, for example, pinching, tapping, and / or clicking the structure to make the interface component 1200 smaller and / or fit to the screen. In some embodiments, the user can manually enter or select a higher percentage of the "actual" or "full" size from a selection table or percentage drop-down menu to zoom in more closely on the interface component 1200, or manually enter or select a lower percentage of the "actual" or "full" size from a selection table or percentage drop-down menu to shrink the interface component 1200 and make the interface component smaller and / or fit to the screen.

[0102] Fig.13 is a block diagram illustrating a 3D infographic associated with a list of antibody products in an interactive 3D graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of immunogen or antigen information, according to various embodiments. In one embodiment, the infographic 1300 facilitates discovery of appropriate antibody products using visual assessment of immunogen or antigen information. In this example, the 3D infographic corresponds to Figure 8C The amino acid sequence information graphs shown in , as they all show information graphs including estimated amino acid values.

[0103] In one embodiment, the 3D amino acid sequence information graph 1300 is visually displayed as a ribbon diagram, also known as a Richardson diagram, which is a 3D schematic representation of a protein structure. In this 3D display format, additional structural elements of the amino acid sequence can be visually indicated. In this example, the information graph 1300 is shown as a strip, which displays the overall path and organization of the protein in 3D, and provides a visual indication of the details of the complete atomic structure of the protein. The secondary structure of the full range of amino acid sequences is shown in the strip, where the spiral and β sheet of the protein are displayed by corkscrews and arrows, respectively. In some embodiments, the α helix is ​​displayed as a curled ribbon or thick tube, and the β strand is displayed as an arrow, and the non-repeating coil or loop is displayed as a line or thin tube. The direction of the amino acid chain is indicated by an arrow. In some embodiments, the direction can be indicated by a color ramp, a color gradient, a pattern density, or other visual indications along the length of the strip as a whole. In addition, the information graph 1300 provides a visual indication of whether the amino acid region of interest includes a coil, a turn, a chain, a spiral, and other visual indications of the molecular structure (including torsion, folding and unfolding).

[0104] In one embodiment, the 3D amino acid sequence information graph 1300 includes an estimated amino acid region 1305, an amino acid left boundary 1310, an amino acid region of interest 1315, an amino acid right boundary 1320, and an estimated amino acid region 1325. The amino acid left boundary 1310 and the amino acid right boundary 1320 indicate the boundary limits of the amino acid region of interest 1315. In some embodiments, the boundary elements may be estimates rather than specific or restrictive boundaries.

[0105] Infographic 1300 is a 3D infographic that includes the entire structure of a protein and a specific amino acid range within the protein that spans residue 25 to residue 45. The amino acid range can be selected and / or identified by a movable line pointing to the location of each residue in the protein structure. Infographic 1300 is shown in a monochrome color scheme throughout the protein structure. In some embodiments, a color scheme can be used. Infographic 1300 includes a visually distinguished immunogen range of 25 to 45. In some embodiments, different colors, different patterns, or border highlights can be used to accomplish visual distinction. Infographic 1300 includes all the features of the amino acid sequence infographics described herein.

[0106] In some embodiments, the information graph 1300 can rotate in response to a user event, which includes, for example, clicking and / or dragging a structure to rotate the information graph. In some embodiments, the information graph 1300 is represented in full 3D using virtual reality or augmented reality technology. In some embodiments, the user can, for example, tap, pinch and / or click the structure to zoom in more closely on the 3D amino acid sequence information graph 1300 and / or make the information graph 1300 larger. In some embodiments, the user can reduce the information graph 1300 by, for example, pinching, tapping and / or clicking the structure to make the information graph 1300 smaller and / or fit into the screen. In some embodiments, the user can manually enter or select a higher percentage of the "actual" or "full" size from a selection table or percentage drop-down menu to zoom in more closely on the information graph 1300, or manually enter or select a lower percentage of the "actual" or "full" size from a selection table or percentage drop-down menu to reduce the information graph 1300 and make the interface component smaller and / or fit into the screen.

[0107] Fig.14 An exemplary computer system is shown that can be configured by a computer program product to implement embodiments of the present invention.

[0108] In this example, computer system 1400 can provide one or more components of an interactive user interface for generating a computer-implemented interactive graphical user interface, which utilizes a visual assessment of immunogen or antigen information to facilitate the discovery of appropriate antibody products. Computer system 1400 executes instruction codes contained in computer program product 1460 (which may, for example, be a part of an interactive 3D graphical user interface, which is used to utilize a visual assessment of immunogen or antigen information as discussed herein to facilitate the discovery of appropriate antibody products). Computer program product 1460 includes executable code in an electronically readable medium, which may indicate that one or more computers (such as computer system 1400) perform the processing of the exemplary method steps performed by the embodiments cited herein. Electronically readable media may be any non-transient medium that stores information electronically and may, for example, be connected locally or remotely via a network. In an alternative embodiment, the medium may be transient. The medium may include a plurality of geographically dispersed media, each of which is configured to store different parts of executable code at different locations or at different times. The executable instruction code in the electronically readable medium indicates that the computer system 1400 shown performs various exemplary tasks described herein. The executable code for indicating the tasks described herein will usually be implemented in software. However, it will be appreciated by those skilled in the art that a computer or other electronic device may utilize the code implemented in hardware to perform many or all of the identified tasks without departing from the present invention. It will be appreciated by those skilled in the art that many variations of the exemplary methods within the spirit and scope of the present invention may be found for the executable code.

[0109] The code or a copy of the code contained in the computer program product 1460 may reside in one or more permanent storage media (not separately shown) communicatively coupled to the computer system 1400 for loading and storage in the permanent storage device 1470, and / or reside in the memory 1410 for execution by the processor 1420. The computer system 1400 also includes an I / O subsystem 1430 and peripherals 1440. The I / O subsystem 1430, the peripherals 1440, the processor 1420, the memory 1410, and the permanent storage device 1470 are coupled via a bus 1450. Similar to the permanent storage device 1470 and any other permanent storage device that may contain the computer program product 1460, the memory 1410 is a non-transitory medium (even if implemented as a typical volatile computer storage device). In addition, those skilled in the art will appreciate that in addition to storing the computer program product 1460 for carrying out the processes described herein, the memory 1410 and / or the permanent storage device 1470 may be configured to store various data elements mentioned and shown herein.

[0110] Those skilled in the art will appreciate that computer system 1400 illustrates only one example of a system in which a computer program product according to an embodiment of the present invention may be implemented. To cite only one example of an alternative embodiment, the storage and execution of instructions contained in a computer program product according to an embodiment of the present invention may be distributed across multiple computers, such as, for example, computers of a distributed computing network.

[0111] Although some of the various embodiments provided herein constitute a single combination of elements of the present invention, it should be understood that the subject matter of the present invention is considered to include all possible combinations of disclosed elements. Therefore, if one embodiment includes elements A, B, and C, and another embodiment includes elements B and D, the subject matter of the present invention is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly discussed herein. In addition, the transition term "comprising" means having parts or components, or these parts or components. As used herein, the transition term "comprising" is inclusive or open-ended, and does not exclude additional, unlisted elements or method steps.

[0112] Any process described herein can be performed in any order, and any step in the process can be omitted. The process can also be combined with the steps of other processes or other processes. Although the steps or operations can be described as sequential processes, some of the steps or operations can actually be performed in parallel, simultaneously and / or in a distributed environment, and the program code is stored locally or remotely for access by a single or multi-processor machine. In addition, in some embodiments, the order of the steps or operations can be rearranged without departing from the essence of the disclosed subject matter.

[0113] Throughout the discussion herein, numerous references are made to clouds, servers, services, devices, platforms, frameworks, cyber-physical systems, or other systems formed by computing devices. It should be understood that the use of such terms is considered to represent at least one or more computing devices having at least one processor, such as (but not limited to) an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), a digital signal processor (DSP), x86, a reduced instruction set computer architecture (ARM), ColdFire, a graphics processing unit (GPU), and a multi-core processor configured to execute software instructions stored on a computer-readable tangible non-transitory medium, such as (but not limited to) a hard drive, a solid-state drive, a random access memory (RAM), flash and read-only memory (ROM), and other components. For example, a server may include one or more computers that operate as a web server, a database server, or other type of computer server in a manner that performs the described roles, responsibilities, or functions. It should also be understood that the disclosed computer-based algorithms, processes, methods, or other types of instruction sets may be embodied as a computer program product including a non-transitory tangible computer-readable medium storing instructions that cause a processor to perform the disclosed steps. Various servers, systems, databases, or interfaces may exchange data using standardized protocols or algorithms, perhaps based on hypertext transfer protocol (HTTP), secure hypertext transfer protocol (HTTPS), advanced encryption standard (AES), public-private key exchange, web service application programming interface (API), known financial transaction protocols, or other electronic information exchange methods. Data exchange may be performed over a packet switching network, a circuit switching network, the Internet, a local area network (LAN), a wide area network (WAN), a virtual private network (VPN), or other types of networks.

[0114] According to some embodiments, a system, server, device, model or other computing element is configured to perform or implement functions on data in a memory, where the meaning of "configured to" or "programmed to" is defined as one or more processors or cores of the computing element being programmed by a set of software instructions stored in the memory of the computing element to perform the set of functions on target data or data objects stored in the memory.

[0115] It should be noted that any language for computing devices should be interpreted as including any suitable combination of computing devices, including servers, interfaces, systems, databases, agents, peers, engines, controllers, modules, or other types of computing devices that operate individually or collectively. It should be understood that the computing device includes a processor configured to execute software instructions stored on a tangible non-transient computer-readable storage medium, such as but not limited to a hard drive, a field programmable gate array (FPGA), a programmable logic array (PLA), a solid-state drive, RAM, flash memory, and ROM. The software instructions configure or program the computing device to provide roles, responsibilities, or other functions as discussed below with respect to the disclosed device. In addition, the disclosed technology may be embodied as a computer program product, which includes a non-transient computer-readable medium storing software instructions, which enables the processor to perform the disclosed steps associated with the implementation of a computer-based algorithm, process, method, or other instruction. In some embodiments, various servers, systems, databases, or interfaces use standardized protocols or algorithms, which may be based on HTTP, HTTPS, AES, public-private key exchange, web service API, known financial transaction protocols, or other electronic information exchange methods, to exchange data. Data exchange between devices may be performed over a packet-switched network, the Internet, a LAN, a WAN, a VPN, or other types of packet-switched networks; circuit-switched networks; cell-switched networks; or other types of networks.

[0116] The systems, devices, and methods described herein may be implemented using a computer program product tangibly embodied in an information carrier, such as a non-transitory machine-readable storage device, for execution by a programmable processor; and the method steps described herein (including, for example, Figure 1 and Figure 2 One or more of the steps of the process may be implemented using one or more computer programs executable by such a processor. A computer program is a set of computer program instructions that can be used directly or indirectly in a computer to perform a certain activity or produce a certain result. A computer program is written in any form of programming language, including compiled languages ​​or interpreted languages, and the computer program may be deployed in any form, including as a separate program or as a module, component, subroutine or other unit suitable for use in a computing environment.

[0117] Although the computing devices described herein (such as but not limited to network nodes, cloud-based models, and virtual machines) may include combinations of hardware components shown, other embodiments may include computing devices with different combinations of components. It should be understood that these computing devices may include any suitable combination of hardware and / or software required to perform the tasks, features, functions, and methods disclosed herein. The determination, calculation, acquisition, or similar operations described herein may be performed by a processing circuit, which may process information by, for example, converting the obtained information into other information, comparing the obtained information or the converted information with the information stored in the network node, and / or performing one or more operations based on the obtained information or the converted information, and making a determination as a result of the processing. In addition, although the components are depicted as being located within a larger frame or a single frame nested within multiple frames, in practice, a computing device may include multiple different physical components constituting a single illustrated component, and functionality may be divided between separate components. For example, a communication interface may be configured to include any one of the components described herein, and / or the functionality of the components may be divided between a processing circuit and a communication interface. In another example, non-computationally intensive functions of any of such components may be implemented in software or firmware, and computationally intensive functions may be implemented in hardware.

[0118] In certain embodiments, some or all of the functionality described herein may be provided by a processing circuit that executes instructions stored on a memory, which in certain embodiments may be a computer program product in the form of a non-transient computer-readable storage medium. In an alternative embodiment, some or all of the functionality may be provided by a processing circuit without executing instructions stored on a separate or discrete device-readable storage medium, such as in a hardwired manner. In any of those specific embodiments, whether or not instructions stored on a non-transient computer-readable storage medium are executed, the processing circuit may be configured to perform the described functionality. The benefits provided by such functionality are not limited to separate processing circuits or other components of a computing device, but are generally enjoyed by computing devices as a whole and / or by end users and wireless networks.

[0119] The disclosed technology is designed to be compatible with and operable by any computing device, including, for example, a desktop computer, a mobile device, a smart phone, an Internet of Things device, an augmented reality or virtual reality device, a personal digital assistant (PDA), a game console or device, a playback appliance, a wearable terminal device, a mobile station, a tablet computer, a laptop computer, or a combination thereof.

[0120] Although some examples described herein may refer to functions being performed by given actors (such as "users," "systems," and / or other entities), it should be understood that this is for purposes of explanation only. The claims should not be interpreted as requiring any such example actor action unless expressly required by the language of the claim itself.

[0121] Many of the details, dimensions, angles, and other features shown in the figures are merely illustrative of specific embodiments of the disclosed technology. Therefore, other embodiments may have other details, dimensions, angles, and features without departing from the spirit or scope of the present disclosure. In addition, those skilled in the art will appreciate that other embodiments of various disclosed technologies may be practiced without some of the details described below.

[0122] Throughout the specification and claims, unless the context clearly dictates otherwise, the following terms shall take the meanings expressly associated herein:

[0123] Although the phrase "in one embodiment" as used herein may refer to the same embodiment, it does not necessarily refer to the same embodiment. Therefore, as described below, the various embodiments of the present invention can be easily combined without departing from the scope or spirit of the present invention.

[0124] As used herein, the term "or" is an inclusive "or" operator, and is equivalent to the terms "and / or" unless the context clearly dictates otherwise.

[0125] The term "based on" is not exclusive and allows for being based on additional factors not described unless the context clearly dictates otherwise.

[0126] As used herein, and unless the context indicates otherwise, the term "coupled to" is intended to include direct coupling (where two elements coupled to each other are in contact with each other) and indirect coupling (where at least one additional element is located between the two elements). Therefore, the terms "coupled to" and "coupled with..." are used synonymously. In the context of a networked environment where two or more components or devices are able to exchange data, the terms "coupled to" and "coupled with..." are also used to mean "communicatively coupled with...", possibly via one or more intermediate devices.

[0127] Furthermore, throughout the specification, the meanings of “a”, “an” and “the” include plural references, and the meaning of “in” includes “in” and “on”.

[0128] Although certain illustrative embodiments are described herein, these embodiments are presented by way of example only and not limitation. Although embodiments have been specifically shown and described, it should be understood that various changes in form and detail may be made. Although various embodiments have been described as having combinations of features and / or components, other embodiments are possible having any combination of features and / or components from any of the embodiments discussed above.

Claims

1. A method for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of sequence information, the method include: In response to user interaction, generating an antibody product list in the graphical user interface, wherein the antibody product list includes at least one antibody product, and the antibody product includes corresponding sequence information and product specifications; generating a sequence information graph based on the corresponding sequence information, wherein the sequence information graph includes indicators of amino acid sequence regions of interest; as well as The sequence information graph is displayed aligned relative to a plurality of sequence information graphs.

2. The method of claim 1, wherein the amino acid sequence region of interest indicator comprises an epitope indicator displayed relative to the amino acid sequence region indicator of the sequence of interest.

3. The method according to claim 2, wherein the sequence information map comprises a base layer representing the amino acid sequence range of a given target protein, a second layer representing the amino acid sequence region indicator of interest, and a third layer representing the epitope.

4. The method of claim 3, wherein the amino acid sequence region of interest indicator comprises a visual element associated with a data point within the amino acid sequence range of the given target protein.

5. A method according to claim 4, wherein the visual element includes at least one of the following: a first visual indicator representing a specific data point, a second visual indicator representing an interval between two data points, a third visual indicator representing an estimated data point, and a fourth visual indicator representing an estimated interval including at least one estimated data point.

6. The method of claim 1, wherein the amino acid sequence region indicator of interest represents at least one of: a specific amino acid sequence value, an amino acid sequence value range, an amino acid sequence starting value, an amino acid sequence ending value, and an amino acid sequence middle value.

7. The method of claim 1, further comprising detecting an input indicating movement of a boundary element associated with the amino acid sequence region of interest, wherein the boundary element represents an amino acid boundary value.

8. The method of claim 7, further comprising updating the list of antibody products within the graphical user interface in response to the input by excluding antibody products having at least one amino acid sequence range value outside of the amino acid boundary values.

9. The method of claim 7, wherein the boundary element comprises a slider visually located at an interval of values ​​representing the range of the amino acid sequence.

10. The method according to claim 9, wherein the positioning of the slider on the interval indicates a boundary value in the amino acid sequence range of the antibody products included in the antibody product list.

11. The method of claim 9, wherein moving the slider from a first position to a second position indicates a change from a first boundary value to a second boundary value.

12. The method of claim 9, wherein moving the slider from a first position to a second position indicates a change in the length of the amino acid sequence range.

13. The method of claim 1, wherein displaying further comprises aligning each of the plurality of sequence information graphs along a visual representation of the amino acid sequence range of the given target protein.

14. The method of claim 1, wherein the sequence information graph enables visual assessment of sequences based on at least one of sequence size, sequence position, and sequence overlap.

15. The method of claim 1, wherein the sequence information comprises one or more of immunogen information, antigen information, and epitope information.

16. The method of claim 1, wherein generating the sequence information graph further comprises generating a three-dimensional model of the sequence information graph including indicators of the amino acid sequence regions of interest.

17. The method of claim 1, further comprising generating a multidimensional protein model representing the plurality of sequence information graphs. 18 . The method of claim 17 , further comprising visually distinguishing each of the plurality of sequence information graphs as a layer of a multidimensional model.

19. The method of claim 18, further comprising visually aligning each layer along the multidimensional model relative to its corresponding amino acid sequence.

20. The method of claim 1, further comprising generating a multidimensional protein model comprising a visual representation of at least one level of protein structure.

21. The method of claim 20, wherein the at least one level of protein structure comprises one of primary protein structure, secondary protein structure, tertiary protein structure, and quaternary protein structure.

22. The method of claim 20, further comprising locating the amino acid sequence region of interest indicator on the at least one level of protein structure.

23. A non-transitory computer-readable medium comprising a memory storing one or more instructions that, when executed by one or more processors of at least one computing device, perform one or more steps for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of sequence information, the one or more steps for generating a computer-implemented interactive graphical user interface being performed by: In response to user interaction, generating an antibody product list in the graphical user interface, wherein the antibody product list includes at least one antibody product, and the antibody product includes corresponding sequence information and product specifications; generating a sequence information map based on the corresponding sequence information, wherein the sequence information map includes indicators of amino acid sequence regions of interest; and The sequence information graph is displayed aligned relative to a plurality of sequence information graphs.

24. The non-transitory computer readable medium of claim 23, wherein the amino acid sequence region of interest indicator comprises an epitope indicator displayed relative to the sequence amino acid sequence region indicator of interest.

25. The non-transitory computer readable medium of claim 24, wherein the sequence information graph comprises a base layer representing the amino acid sequence range of a given target protein, a second layer representing the amino acid sequence region indicator of interest, and a third layer representing epitopes.

26. The non-transitory computer readable medium of claim 25, wherein the amino acid sequence region of interest indicator comprises a visual element associated with a data point within the amino acid sequence range of the given target protein.

27. A non-transitory computer-readable medium according to claim 26, wherein the visual element includes at least one of the following: a first visual indicator representing a specific data point, a second visual indicator representing an interval between two data points, a third visual indicator representing an estimated data point, and a fourth visual indicator representing an estimated interval including at least one estimated data point.

28. The non-transitory computer-readable medium of claim 23, wherein the amino acid sequence region of interest indicator represents at least one of: a specific amino acid sequence value, a range of amino acid sequence values, an amino acid sequence starting value, an amino acid sequence ending value, and an amino acid sequence middle value.

29. The non-transitory computer readable medium of claim 23, further comprising detecting an input indicative of movement of a boundary element associated with the amino acid sequence region of interest, wherein the boundary element represents an amino acid boundary value.

30. The non-transitory computer-readable medium of claim 25, further comprising updating the list of antibody products within the graphical user interface in response to the input by excluding antibody products having at least one amino acid sequence range value outside of the amino acid boundary values.

31. The non-transitory computer readable medium of claim 25, wherein the boundary element comprises a slider visually positioned at an interval of values ​​representing the range of amino acid sequences.

32. The non-transitory computer readable medium of claim 31, wherein the positioning of the slider on the interval indicates a boundary value in the amino acid sequence range of antibody products included in the antibody product list.

33. The non-transitory computer readable medium of claim 31, wherein moving the slider from a first position to a second position indicates a change from a first boundary value to a second boundary value.

34. The non-transitory computer readable medium of claim 31, wherein moving the slider from a first position to a second position indicates a change in the length of the amino acid sequence range.

35. The non-transitory computer readable medium of claim 23, wherein displaying further comprises aligning each of the plurality of sequence information graphs along a visual representation of the amino acid sequence range of the given target protein.

36. The non-transitory computer readable medium of claim 23, wherein the sequence information graph enables visual assessment of the sequences based on at least one of sequence size, sequence position, and sequence overlap.

37. The non-transitory computer readable medium of claim 23, wherein the sequence information comprises one or more of immunogen information, antigen information, and epitope information.

38. The non-transitory computer readable medium of claim 23, wherein generating the sequence information graph further comprises generating a three-dimensional model of the sequence information graph including the amino acid sequence region of interest indicators.

39. The non-transitory computer readable medium of claim 23, further comprising generating a multi-dimensional protein model representing the plurality of sequence information graphs.

40. The non-transitory computer readable medium of claim 23, further comprising visually distinguishing each of the plurality of sequence information graphs as a layer of a multi-dimensional model.

41. The non-transitory computer readable medium of claim 23, further comprising visually aligning each layer along the multidimensional model relative to its corresponding amino acid sequence.

42. The non-transitory computer readable medium of claim 23, further comprising generating a multi-dimensional protein model comprising a visual representation of at least one level of protein structure.

43. The non-transitory computer readable medium of claim 42, wherein the at least one level of protein structure comprises one of a primary protein structure, a secondary protein structure, a tertiary protein structure, and a quaternary protein structure.

44. The non-transitory computer readable medium of claim 42, further comprising locating the amino acid sequence region of interest indicator on the at least one level of protein structure. 44A. The non-transitory computer-readable medium of claim 42, further comprising rotating the multidimensional protein model around an axis in response to a click or drag event by a user to generate different visual representations of the protein structure of at least one level.

45. A method for generating a computer-implemented interactive graphical user interface for facilitating discovery of appropriate antibody products using visual assessment of sequence information, the method comprising within the computer-implemented graphical user interface: generating a dynamic amino acid sequence filter element comprising at least one movable boundary indicator, wherein the dynamic filter element visually represents an amino acid sequence range of a given target protein, and wherein the at least one movable boundary indicator visually represents a specific amino acid within the amino acid sequence range; and Based on the position of the at least one movable boundary indicator on the dynamic amino acid sequence filter element corresponding to the specific amino acid, an amino acid sequence region of interest within the dynamic amino acid sequence filter element is visually distinguished.

46. ​​The method of claim 45, further comprising updating a list of antibody products within the graphical user interface in response to user input by excluding antibody products having at least one amino acid sequence range value outside of the amino acid sequence region of interest.

47. The method of claim 45, wherein the at least one movable boundary indicator comprises a slider visually positioned on an edge of the amino acid sequence region of interest.

48. The method of claim 47, wherein the positioning of the slider over the amino acid sequence region of interest indicates a boundary value in the amino acid sequence range of antibody products included in the antibody product list.

49. The method of claim 47, wherein moving the slider from a first position to a second position indicates a change from a first boundary value to a second boundary value.

50. The method of claim 47, wherein moving the slider from a first position to a second position indicates a change in the length of the amino acid sequence of interest.

51. The method of claim 45, further comprising a dynamic pick list within the computer-implemented interactive graphical user interface, wherein the dynamic pick list comprises one or more of the specific amino acids or amino acid sequence ranges for the given target protein and is responsive to user input to select at least one of the specific amino acids or amino acid sequence ranges.

52. The method of claim 45, further comprising a numerical input interface within the computer-implemented graphical user interface, wherein the numerical input interface is responsive to user input to manually enter one or more of the specific amino acids or amino acid sequence ranges for the given target protein.